课题基金 / 基金详情

Developing a polygenic score to aid in the prediction of cisplatin-induced ototoxicity

Developing a polygenic score to aid in the prediction of cisplatin-induced ototoxicity
开发多基因评分以帮助预测顺铂引起的耳毒性
批准号：
449433
负责人：
Sarvis MacKenzie A
金额：
$1.27万
依托单位：
University of Manitoba
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2020
资助国家：
加拿大
项目状态：
已结题
起止时间：
2020-12-01 至 2021-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=449433&lang=en
关键词：
Adverse Drug Reactions Audiology Cisplatin-Induced Ototoxicity Genome-Wide Association Study Hearing Loss Inner Hair Cells Pediatric Oncology Pharmacogenomics Polygenic Scores Precision Medicine

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
顺铂是一种常见且有效的化疗药物，用于治疗许多不同类型的癌症，与许多化疗药物一样，它会损害肿瘤和健康细胞。顺铂最常见的药物不良反应之一是
英文摘要
Cisplatin is a common and effective chemotherapy drug which is used to treat many different types of cancer, and as with many chemotherapeutics, it harms both tumour and healthy cells. One of the most frequent adverse drug reactions seen with cisplatin is
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金